Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA+ channel feed
European regulator rejects Lilly's Alzheimer’s drug over potentially fatal side effects
2 months ago
Pharma
FDA’s policy, communications staff likely to be among agency’s 3,500 staff cuts
2 months ago
Law
Kennedy announces 10,000 job cuts at HHS, with major reductions expected at FDA, NIH and CDC
2 months ago
Pharma
FDA approves first drug for Prader-Willi syndrome, to tamp down insatiable hunger symptoms
2 months ago
R&D
FDA critiques Taiho Oncology's 'misleading' promotional website for bile duct cancer drug
2 months ago
Senate confirms Makary as FDA chief with agency cuts, return-to-office in force
2 months ago
R&D
Pharma
Covid contrarian Bhattacharya is confirmed as NIH chief, taking over at a fraught moment for federal research
2 months ago
People
DOGE pulls three FDA lease closures from 'Wall of Receipts,' including St. Louis quality lab
2 months ago
GSK scores FDA approval for antibiotic to treat uncomplicated UTIs
2 months ago
Pharma
Trump taps acting CDC chief Susan Monarez for permanent role
2 months ago
People
FDA's biologics chief stresses need for vaccine transmission data despite high costs to generate
2 months ago
R&D
Liver cancer drug combo gets second FDA rejection over manufacturing issues
2 months ago
Pharma
Manufacturing
Alnylam hopes its broad ATTR-CM label can give Amvuttra an edge in heart disease
2 months ago
Pharma
BARDA cancels annual biomedical event for industry, government reps
2 months ago
Pharma
FDA approves Novartis’ Fabhalta in another rare kidney disease
2 months ago
Pharma
Updated: FDA approves Alnylam’s Amvuttra in ATTR-CM, kicking off competition with Pfizer, BridgeBio
2 months ago
Pharma
Akero exec calls FDA's accelerated approval guidance for MASH drugs 'bizarre'
2 months ago
R&D
Pharma
Two-thirds of recent rare disease drugs relied on just one trial, plus confirmatory evidence, FDA team finds
2 months ago
DOJ lawyers defend abortion pill restrictions in new court filing
2 months ago
Law
Ahead of FDA decision, Alnylam faces the big question: Can it make money?
2 months ago
Pharma
In Focus
FDA staff return to White Oak campus en masse after Trump administration push
2 months ago
All selected drugmakers agree to second round of price negotiations under the IRA
2 months ago
Pharma
Post-Hoc: Kennedy's anti-vaccine actions shouldn't surprise anyone
2 months ago
Pharma
'It’s the law’: Dr. Oz says he would defend Medicare drug price negotiations
2 months ago
Pharma
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit